INNOVA CAPTAB
Back to Income Statement
|
INNOVA CAPTAB Last 5 Year Revenue History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Sales | ₹1,081 Cr | ₹926 Cr | ₹801 Cr | ₹411 Cr | ₹373 Cr |
What is the latest Revenue of INNOVA CAPTAB ?
Year | Revenue |
---|---|
Mar2024 | ₹1,081 Cr |
Mar2023 | ₹926 Cr |
Mar2022 | ₹801 Cr |
Mar2021 | ₹411 Cr |
Mar2020 | ₹373 Cr |
How is Revenue of INNOVA CAPTAB Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2024 | ₹1,081 Cr | 16.72 | |
Mar2023 | ₹926 Cr | 15.72 | |
Mar2022 | ₹801 Cr | 94.94 | |
Mar2021 | ₹411 Cr | 10.00 | |
Mar2020 | ₹373 Cr | - |
Compare Revenue of peers of INNOVA CAPTAB
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
INNOVA CAPTAB | ₹4,950.1 Cr | -1.9% | -7.3% | 82% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹405,068.0 Cr | 1.4% | 0.1% | 13.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹177,105.0 Cr | 0.8% | 12.3% | 47.2% | Stock Analytics | |
CIPLA | ₹122,016.0 Cr | 2.6% | -0.1% | 0.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹112,651.0 Cr | 7.8% | 12.9% | 13.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹108,942.0 Cr | 2.7% | -0.6% | 14.4% | Stock Analytics |
INNOVA CAPTAB Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
INNOVA CAPTAB | -1.9% |
-7.3% |
82% |
SENSEX | 2.1% |
3.7% |
14.3% |
You may also like the below Video Courses